The clinical efficacy of low-dose step-up follicle stimulating hormone administration for treatment of unexplained infertility (original) (raw)
Role of Dominant Follicle Count in Controlled Ovarian Stimulation with Intrauterine Insemination Cycles in Patients with Unexplained Infertility
hüseyin durukan
Zeynep Kamil Tıp Bülteni, 2014
View PDFchevron_right
Debate- The current role of intrauterine insemination for the treatment of male factor and unexplained infertility
Ibrahim Fahmy
View PDFchevron_right
Success of Controlled Ovarian Hyperstimulation and Intrauterine Insemination in couple with Unexplained Infertility
Nazdar Raouf, Fortune Journals
View PDFchevron_right
Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome
fernando bonilla
Human Reproduction, 1999
View PDFchevron_right
Follicle stimulating hormone versus clomiphene citrate in intrauterine insemination for unexplained subfertility: a randomized controlled trial
Bwj Mol
Human Reproduction
View PDFchevron_right
High follicle-stimulating hormone levels should not necessarily lead to the exclusion of subfertile patients from treatment
Frank Broekmans
Fertility and Sterility, 2004
View PDFchevron_right
In-Vitro Fertilization Outcome Predictors in Women With High Baseline Follicle-Stimulating Hormone Levels: Analysis of Over 1000 Cycles From A Tertiary Center
Aysin Akdogan
JBRA Assisted Reproduction
View PDFchevron_right
Basal follicle stimulating hormone (FSH) predicts response to controlled ovarian hyperstimulation (COH)intrauterine insemination (IUI) therapy
Thomas Burwinkel
Journal of Assisted Reproduction and Genetics, 1994
View PDFchevron_right
TWO DAYS MINIMAL STIMULATION PROTOCOL WITH INTRAUTERINE INSEMINATION IN THE TREATMENT OF UNEXPLAINED INFERTILITY.
IJAR Indexing
View PDFchevron_right
The safety and effectiveness of stepwise and low-dose administration of follicle stimulating hormone in WHO group II anovulatory infertile women: Evidence from a large multicenter study in Spain
isidoro bruna
Journal of Assisted Reproduction and Genetics, 1996
View PDFchevron_right
Randomized controlled trial comparing superovulation with letrozole versus recombinant follicle-stimulating hormone combined with intrauterine insemination for couples with unexplained infertility who had failed clomiphene citrate stimulation and intrauterine insemination
Nikos Vlahos
Fertility and Sterility, 2008
View PDFchevron_right
A comparative prospective study of a chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle stimulating hormone in anovulatory infertile women
Colin Howles
Human Reproduction, 1998
View PDFchevron_right
A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment
peter yong
Fertility and Sterility, 2003
View PDFchevron_right
Role of antral follicle count in controlled ovarian hyperstimulation and intrauterine insemination cycles in patients with unexplained subfertility
Ahmet Erdem
Fertility and Sterility, 2008
View PDFchevron_right
Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone–stratified, dose–response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection
Ernesto Bosch
Fertility and Sterility, 2014
View PDFchevron_right
A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial
Marlene Goldman
Fertility and Sterility, 2010
View PDFchevron_right
Intrauterine insemination with controlled ovarian hyperstimulation in the treatment of subfertility
Rozina Sikandar
Journal of the College of Physicians and Surgeons--Pakistan: JCPSP
View PDFchevron_right
Low dose recombinant FSH treatment may reduce multiple gestations caused by controlled ovarian hyperstimulation and intrauterine insemination
Juliette Guibert
BJOG: An International Journal of Obstetrics & Gynaecology, 2004
View PDFchevron_right
A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count
Dr. K. Jayaprakasan
BJOG : an international journal of obstetrics and gynaecology, 2010
View PDFchevron_right
A prospective randomized noninferiority study comparing recombinant FSH and highly purified menotropin in intrauterine insemination cycles in couples with unexplained infertility and/or mild-moderate male factor
Daniela Martinez
Fertility and Sterility, 2011
View PDFchevron_right
Recombinant Follicle-Stimulating Hormone in the Treatment of Patients with History of Severe Ovarian Hyperstimulation Syndrome
Mohamed Aboulghar
Fertility and Sterility, 1998
View PDFchevron_right
One triplet pregnancy in 510 controlled ovarian hyperstimulation and intrauterine insemination cycles
Gab Kovacs
Fertility and Sterility, 2003
View PDFchevron_right
DUAL OVULATION TRIGGERING WITH FOLLICLE-STIMULATING HORMONE AND HUMAN CHORIONIC GONADOTROPIN IN WOMEN WITH UNEXPLAINED INFERTILITY UNDERWENT LETROZOLE SUPEROVULATION AND INTRAUTERINE INSEMINATION: A RANDOMIZED CONTROLLED TRIAL.
IJAR Indexing
View PDFchevron_right
Effectiveness of HP-hMG vs r-FSH in Patients Undergoing IVF/ICSI Cycles with Moderate Male Factor Infertility
Nandita Palshetkar
International Journal of Infertility & Fetal Medicine, 2012
View PDFchevron_right
Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: A prospective, randomized study with cost-minimization analysis
M. Massobrio
2006
View PDFchevron_right
The Clinical Efficacy of Three Different Follicle-Stimulating Hormones for Follicle Growth and Development in Long-Protocol Controlled Ovarian Hyperstimulation Treatment
QIANWEN HUANG
Drug Design, Development and Therapy, 2021
View PDFchevron_right
Comparison of different gonadotrophin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective, randomized study
Timur Gürgan
Human Reproduction, 2006
View PDFchevron_right
Diagnosis and management of unexplained infertility: an update
Mohamed Aboulghar
Archives of gynecology and obstetrics, 2003
View PDFchevron_right
Preventing high-order multiple pregnancies during controlled ovarian hyperstimulation and intrauterine insemination: 3 years’ experience using low-dose recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists
Guido Ragni, P. Crosignani, Edgardo Somigliana
Fertility and Sterility, 2006
View PDFchevron_right
A Randomized, Double-Blind, Multicenter Study Comparing a Starting Dose of 100 IU or 200 IU of Recombinant Follicle Stimulating Hormone (Puregon�) in Women Undergoing Controlled Ovarian Hyperstimulation for IVF Treatment
Seang Lin Tan
Journal of Assisted Reproduction and Genetics, 2005
View PDFchevron_right
Follicle stimulating hormone as a predictor of ovarian response in women undergoing controlled ovarian hyperstimulation for IVF
m ashrafi
International Journal of Gynecology & Obstetrics, 2005
View PDFchevron_right